journal article·2026

Retina-targeted siRNA delivery via exosome–liposome hybrid vesicles for AMD treatment

Yangyang Huang, Xingyu Zhu, Ruiyang Lu, Kai Jiang, Lijuan Zhu, Xujiao Zhou, Jiaxu Hong, Chuan Zhang

Biomaterials Science· Volume 14· Issue 12
Publisher page

Abstract

Effective treatment of neovascular age-related macular degeneration (AMD) requires targeted inhibition of vascular endothelial growth factor (VEGF) within the retina. However, delivering therapeutic siRNA to the retinal pigment epithelium (RPE), a key source of pathogenic VEGF, remains a major challenge due to ocular barriers and poor cellular tropism. To address this, we developed a retina-targeted delivery system by engineering exosome-liposome hybrid vesicles that encapsulate VEGF-silencing siRNA (Hybrid-siVEGF). The hybrid design leverages the innate homing capability of RPE-derived exosomes for retinal targeting, combined with the high siRNA loading capacity of synthetic liposomes. In vitro, Hybrid-siVEGF showed significantly enhanced uptake by human RPE cells compared to conventional liposomes, leading to the potent and specific knockdown of VEGF expression and the subsequent inhibition of endothelial cell proliferation. In vivo, a single intravitreal injection of Hybrid-siVEGF in a laser-induced choroidal neovascularization mouse model resulted in efficient accumulation within the retina, significant suppression of pathological angiogenesis, preservation of retinal morphology, and restoration of visual function. Our work establishes exosome-liposome hybrids as an effective and targeted platform for ocular siRNA delivery, offering a promising strategy for RNAi-based therapy for AMD and other retinal disorders.
Source: europepmc · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Extracellular vesicles in disease · RNA Interference and Gene Delivery · Polydiacetylene-based materials and applications

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

School of Chemistry and Chemical Engineering, State Key Laboratory of Synergistic Chem-Bio Synthesis, Frontiers Science Center for Transformative Molecules, Shanghai Key Laboratory for Molecular Engineering of Chiral Drugs, Shanghai Jiao Tong University, Shanghai, 200240, China

Department of Ophthalmology and Vision Science, Eye & ENT Hospital, State Key Laboratory of Brain Function and Disorders; NHC Key Laboratory of Myopia and Related Eye Diseases Shanghai; Shanghai Key Laboratory of Rare Disease Gene Editing and Cell Therapy, Fudan University, Shanghai, 200031, China

Institute of Photochemistry and Photofunctional Materials, School of Materials and Chemistry, University of Shanghai for Science and Technology, Shanghai, 200093, China

Funding

National Natural Science Foundation of China · National Key Research and Development Program of China · Shanghai Municipal Education Commission · Shanghai Jiao Tong University

References (46)

Show source-provided references
1. Fleckenstein · J. Am. Med. Assoc. · 2024 · 331 · 14710.1001/jama.2023.26074 ↗
2. Li · Br. J. Ophthalmol. · 2020 · 104 · 107710.1136/bjophthalmol-2019-314422 ↗
3. Ambati · Neuron · 2012 · 75 · 2610.1016/j.neuron.2012.06.018 ↗
4. Witmer · Prog. Retinal Eye Res. · 2003 · 22 · 110.1016/S1350-9462(02)00043-5 ↗
5. Ikeda · Exp. Eye Res. · 2006 · 83 · 103110.1016/j.exer.2006.05.007 ↗
6. Fuhrmann · Exp. Eye Res. · 2014 · 123 · 14110.1016/j.exer.2013.09.003 ↗
7. Ponnalagu · Cytokine · 2017 · 95 · 12610.1016/j.cyto.2017.02.013 ↗
8. Mohr · Invest. Ophthalmol. Visual Sci. · 2015 · 56 · 640410.1167/iovs.15-16898 ↗
9. Fleckenstein · Nat. Rev. Dis. Primers · 2021 · 7 · 3110.1038/s41572-021-00265-2 ↗
10. Campochiaro · J. Cell Physiol. · 2000 · 184 · 30110.1002/1097-4652(200009)184:3<301::AID-JCP3>3.0.CO;2-H ↗
11. Zhao · Adv. Mater. · 2022 · 34 · e210836010.1002/adma.202108360 ↗
12. Shen · Sci. Adv. · 2023 · 9 · eabq310410.1126/sciadv.abq3104 ↗
13. Ng · Expert Opin. Biol. Ther. · 2020 · 20 · 138510.1080/14712598.2021.1830969 ↗
14. Garcia · Cancer Treat. Rev. · 2020 · 86 · 10201710.1016/j.ctrv.2020.102017 ↗
15. Ng · Nat. Rev. Drug Discovery · 2006 · 5 · 12310.1038/nrd1955 ↗
16. Ryoo · Nanoscale · 2017 · 9 · 1546110.1039/C7NR03142D ↗
17. Abedi · Nucleic Acids Res. · 1998 · 26 · 62310.1093/nar/26.2.623 ↗
18. Ambati · Retina · 2025 · 45 · 44610.1097/IAE.0000000000004322 ↗
19. Wojciechowski · Ophthalmol. Ther. · 2025 · 14 · 73310.1007/s40123-025-01098-y ↗
20. Gallas · Chem. Soc. Rev. · 2013 · 42 · 798310.1039/c3cs35520a ↗
21. Ranasinghe · Br. J. Pharmacol. · 2023 · 180 · 269710.1111/bph.15972 ↗
22. Liu · Signal Transduction Targeted Ther. · 2025 · 10 · 7310.1038/s41392-024-02112-8 ↗
23. Tang · Nat. Rev. Drug Discovery · 2024 · 23 · 34110.1038/s41573-024-00912-9 ↗
24. Hoon · Prog. Retinal Eye Res. · 2014 · 42 · 4410.1016/j.preteyeres.2014.06.003 ↗
25. Hurst · Adv. Funct. Mater. · 2025 · 35 · 20240717310.1002/adfm.202407173 ↗
26. Moazzam · Mol. Ther. · 2024 · 32 · 28410.1016/j.ymthe.2024.01.005 ↗
27. Sarisozen · Curr. Pharm. Biotechnol. · 2016 · 17 · 72810.2174/1389201017666160401145319 ↗
28. Cullis · Nat. Rev. Drug Discovery · 2024 · 23 · 70910.1038/s41573-024-00977-6 ↗
29. Song · Int. J. Pharm. · 2021 · 592 · 12003310.1016/j.ijpharm.2020.120033 ↗
30. Su · ACS Nano · 2024 · 18 · 2279310.1021/acsnano.4c08486 ↗
31. Mehdizadeh · J. Nanobiotechnol. · 2025 · 23 · 32910.1186/s12951-025-03352-8 ↗
32. Su · Int. J. Nanomed. · 2025 · 20 · 317510.2147/IJN.S502591 ↗
33. Wang · Drug Delivery · 2021 · 28 · 21810.1080/10717544.2020.1870584 ↗
34. Tang · J. Controlled Release · 2023 · 357 · 35610.1016/j.jconrel.2023.04.003 ↗
35. Lu · Asian J. Pharm. Sci. · 2018 · 13 · 1
36. Evers · Adv. Healthcare Mater. · 2022 · 11 · e210120210.1002/adhm.202101202 ↗
37. Xie · Adv. Mater. · 2024 · 36 · e240393510.1002/adma.202403935 ↗
38. Edelmann · Zoonoses · 2022 · 2 · 1410.15212/ZOONOSES-2022-0004 ↗
39. Shah · J. Visualized Exp. · 2015 · 106 · e53502
40. Zhang · Oxid. Med. Cell. Longevity · 2023 · 3310621
41. Young · Exp. Eye Res. · 2005 · 80 · 65110.1016/j.exer.2004.11.015 ↗
42. Kwon · Adv. Ther. · 2024 · 7 · 240003010.1002/adtp.202400030 ↗
43. Liang · Cell Discovery · 2025 · 11 · 910.1038/s41421-024-00760-2 ↗
44. Sun · Mol. Cell. Biol. · 2017 · 37 · e00569–1610.1128/MCB.00569-16 ↗
45. Gong · PLoS One · 2015 · 10 · e013264310.1371/journal.pone.0132643 ↗
46. Gu · Exp. Eye Res. · 2010 · 91 · 43310.1016/j.exer.2010.06.019 ↗